- Home
- Solutions
- Laboratories
- Specialty Laboratories
- Customised Assay Development
Customised Assay Development
Managing risks, timelines and budgets to effectively move trials forward
Clinical trial assays often change over the course of a trial, requiring a diagnostic partner that can closely manage these changes.
Our Specialty Laboratories have experience with assay development, validation, bridging and regulatory interactions, which are critical to the success of therapeutic programmes. Moreover, we collaborate with clients to manage risks, timelines and budgets to effectively move trials forward.
Clinical Trial Assay and IVD Development
Our development services segment is oriented around the development, validation, and regulatory approval of companion diagnostics, providing high-quality biomarker diagnostic services that support the registration of oncology therapeutics. Upon biomarker selection, we have experience designing FDA CFR Title 21 Part 820-compliant assays across multiple diagnostic providers’ IVD platforms. We manage the full PMA/investigational device exemption (IDE) submission process through FDA approval via scientific/technical expertise and dedicated project and quality assurance/regulatory teams.
R&D/Advanced Diagnostics
Our Advanced Diagnostics Division provides custom oncology clinical trial assay development and bioinformatics support using validated NGS panels which can generate endpoint and exploratory data. In addition, our team is responsible for ddPCR and liquid biopsy services.
The robust diagnostic assays developed and/or optimised are deployed for diagnostic, stratification and monitoring applications. Programme managers facilitate cross-functional teams to ensure efficient tech transfers and organise comprehensive documentation to support potential regulatory filings. Key features include:
- Demonstrated proficiency on platforms for NextGen Sequencing, Droplet Digital PCR (ddPCR), RT-qPCR, qPCR and Sanger Sequencing
- On-site access to prominent instrument manufacturers
- Partnership agreements with instrument manufacturers for a high level of technical and regulatory support
- Proficiency with pre-analytical analyte isolation, qualification and quantification from all tissue types (i.e., blood, plasma, PBMCs, solid tumor (FFPE and fresh frozen))
- Development of rigorous audit-defensible documentation and software validation
PCR-specific Testing
Therapeutic Area | qPCR | RT-qPCR | ddPCR |
Cell & Gene Therapies
|
RCR & RCL Testing
|
Target Gene Expression
|
Vector Copy Number
Liquid Biopsy
|
Checkpoint Inhibitor
Therapies
|
Activating Mutations
|
Gene Expression
|
Gene Expression
Liquid Biopsy
|
Targeted Therapies
|
Activating Mutations
Resistance Mutations
Monitoring & MRD
|
Target Gene Expression
Monitoring & MRD
|
Activating Mutations
Resistance Mutations
Monitoring & MRD
Liquid Biopsy
|
Infectious Disease
|
HIV, HCV, HBV
|
COVID-19
C. Difficile
HIV, HCV, HBV
|
COVID-19
|
Pharmacogenetics
|
Germline
Polymorphisms (PGX)
|
|
|
In this section
- Asset Development Consulting
-
Blended Solutions
-
Cardiac Safety Solutions
-
Clinical & Scientific Operations
- Biostatistics
-
Case studies
- Clinical Operations
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Site Identification and Feasibility
- Commercial Positioning
- Decentralised Clinical Trials
-
Early Clinical
-
Bioanalytical Laboratories
-
Biometrics
-
Clinical Pharmacology
-
Clinical Research Facilities
-
Adaptive Pharmaceutical Services
-
Early Phase Oncology
-
Early Phase Patient Studies
-
Early Phase Obesity Trials
-
PK/PD Modeling and Simulation
-
Quality and Compliance
-
Quantitative Pharmacology and Pharmacometrics
-
Volunteer Recruitment
-
Bioanalytical Laboratories
- Language Services
-
Laboratories
- Medical Imaging
- Outcome Measures
- Real World Intelligence
- Regulatory Affairs
- Symphony Health data
- Site & Patient Solutions
- Strategic Solutions
-
Technologies